Attachment II

Center for Science in the Public Interest
Olestra Adverse-reaction Reports
Seventh Report to the FDA

Number of Reports: 206
Received between May 5, 2000 and January 31, 2002

 

1. Age
<10 years old 6 (3%)
10-19 16 (8%)
20-29 51 (25%)
30-39 60 (29%)
40-49 42 (20%)
50-59 21 (10%)
60-69 5 (2%)
70 and up 4 (2%)
2. Gender
Male 47 (23%)
Female 157 (77%)
3. Severe symptoms
Diarrhea 65 (32%)
Couldn’t control bowels; soiled clothing 35 (16%)
Loose stools 48 (23%)
Nausea 19 (9%)
Fecal urgency 73 (35%)
Gas 79 (38%)
Bloating 51 (25%)
Cramps 93 (45%)
Vomiting 9 (5%)
Yellow-orange stains in underwear 21 (10%)
Greasy stools 44 (21%)
Oil in toilet 42 (20%)
4. One or more severe symptoms indicated 165 (80%)
5. History of gastrointestinal problems
Yes 36 (18%)
No 169 (82%)
6. Experienced safety problems 107 (52%)

Return

[CSPI U.S.] [News Releases]
CSPI NAH Subscribe